Skip to main content

Derm Q&A

Melissa Weiss, Associate Editor
A recent study evaluated providers’ perceptions of a universal action plan for the management of atopic dermatitis. Corresponding author Collette Utley, DNP, FNC-BC, PNP-BC, discussed the action plan and how it could help physicians in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
A recent cross-sectional study highlighted the reasons dermatologists were sanctioned by the Office of the Inspector General in the United States. In an interview with The Dermatologist, study authors Savannah Alvarado and Hao Feng, MD, discuss their findings and implications for clinical practice.
Findings from a recent study highlighted key differences between the molecular phenotype of mild atopic dermatitis and moderate to severe atopic dermatitis. Corresponding author Emma Guttman, MD, PhD, discussed the implications of these key differences for clinical practice and research.
Melissa Weiss, Associate Editor
A recent study showed patients with Down syndrome are more likely to develop hidradenitis suppurativa compared with individuals without Down syndrome. Corresponding author Raed Alhusayen, MBBS, MSCE, FRCPC, discussed these findings in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
Andrew Alexis, MD, discussed the treatment of acne and postinflammatory hyperpigmentation among skin of color patients in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
Crystal Aguh, MD, presented on alternative treatments for patients with hair loss who may not be responding to conventional therapies at the Skin of Color Update. She discussed important treatment considerations for managing hair loss in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
Amy McMichael, MD, presented on photoprotection at the Skin of Color Update. She discussed hot topics and misunderstandings regarding sunscreen use among patients with skin of color in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
Amy McMichael, MD, discussed some common types of alopecias, including ones known to predominately affect patients with skin of color, and shared important pitfalls to keep in mind when treating patients with hair loss.
Melissa Weiss, Associate Editor
A recent systematic review analyzed the role of multidisciplinary clinics for the treatment of patients with psychocutaneous diseases, including delusional infestation. Corresponding author Mohammad Jafferany, MD, discussed these findings further in an interview with The Dermatologist.
Melissa Weiss, Associate Editor
Tuberous sclerosis complex (TSC) is a rare, multiorgan, genetic disease with many cutaneous findings. In an interview with The Dermatologist, Elizabeth Thiele, MD, PhD, director of the TSC Center at Harvard Medical School, discusses common cutaneous symptoms of this disease.
Back to Top